![A Phase I-II Study of the Oral Poly(ADP-ribose) Polymerase Inhibitor Rucaparib in Patients with Germline BRCA1/2-mutated Ovarian Carcinoma or Other Solid Tumors]()
A Phase I-II Study of the Oral Poly(ADP-ribose) Polymerase Inhibitor Rucaparib in Patients with Germline BRCA1/2-mutated Ovarian Carcinoma or Other Solid TumorsKristeleit, Rebecca; Shapiro, Geoffrey I.; Burris, Howard A.; Oza, Amit M; LoRusso, Patricia M.; Patel, Manish; Domchek, Susan M.; Balmaña, Judith; Drew, Yvette; Chen, Lee-may; Safra, Tamar; Montes, Ana; Giordano, Heidi; Maloney, Lara; Goble, Sandra; Isaacson, Jeff; Xiao, Jim; Borrow, Jen; Rolfe, Lindsey; Shapira-Frommer, Ronnie · Clinical Cancer Research · 2017